Children in Critical Care Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Experience in a Spanish

Alberto García-Salido1, Inés Leoz-Gordillo, Amelia Martínez de Azagra-Garde

  • 1All authors: Pediatric Critical Care Unit, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

Insights

This study observed children with coronavirus disease 2019 (COVID-19) in Spain. Most previously healthy children required respiratory support, with some needing mechanical ventilation shortly after PICU admission.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Spain experienced severe impacts from the coronavirus disease 2019 (COVID-19) pandemic.
  • Pediatric intensive care units (PICUs) managed children with severe COVID-19.
  • Understanding COVID-19's pediatric impact is crucial for effective treatment.

Purpose of the Study:

  • To describe the clinical characteristics and outcomes of children admitted to a PICU with COVID-19.
  • To analyze the management and therapeutic interventions for severe pediatric COVID-19 cases.
  • To identify factors associated with critical illness in children with COVID-19.

Main Methods:

  • Prospective observational study conducted in a tertiary hospital in Madrid, Spain.
  • Inclusion criteria: Children admitted to the PICU with confirmed or suspected COVID-19 between March 1 and April 15, 2020.
  • Data collected: Epidemiologic, clinical, laboratory, imaging, and therapeutic information.

Main Results:

  • Eleven children were admitted to the PICU; seven tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
  • The majority were previously healthy, with respiratory symptoms and fever being prevalent.
  • Respiratory support was essential, with two patients requiring mechanical ventilation on admission; no deaths occurred.

Conclusions:

  • Children admitted to the PICU for COVID-19 were generally healthy and over one year old.
  • Respiratory failure was the primary reason for PICU admission, necessitating significant respiratory support.
  • Close monitoring and further multicenter studies are recommended for severe pediatric COVID-19 cases.
Abstract

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...